The experimental upregulation of NF-κB in β-cells using transgenic mice has been shown to cause reduced β-cell mass and diabetes (Salem et al., 2014), whereas genetic inhibition of NF-κB has protective effects (Eldor et al., 2006). This evidence concerns the gene NFKB1 and diabetes mellitus.